tDCS Plus Varenicline for Smoking Cessation
RecruitingNCT06798324Phase: PHASE4Started 2025-03-10
Summary
The goal of this clinical trial is to determine if active transcranial direct current stimulation (tDCS) plus varenicline is an effective, safe and accessible treatment option for smoking cessation. T
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
85 Years
Locations
Centre for Addiction and Mental HealthToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06798324